Defective monocyte plasticity and altered cAMP pathway characterize USB1-mutated poikiloderma with neutropenia

Prahlad Parajuli1,2, Douglas B Craig2,3, Manisha Gadgeel4,5

  • 1Department of Pharmaceutical and Health Sciences, Eugene Applebaum College of Pharmacy, Wayne State University, Detroit, Michigan, USA.

PubMed

Insights

Poikiloderma with neutropenia (PN) patients lack a specific monocyte population, impacting immune cell function. This study links USB1 mutations to defective cyclic adenosine monophosphate (cAMP) signaling and monocyte plasticity issues in PN.

Area of Science:

  • Genetics and Immunology
  • Rare Diseases Research

Background:

  • Poikiloderma with neutropenia (PN) Clericuzio type is a rare genetic disorder characterized by skin pigmentation changes and neutropenia, caused by biallelic USB1 variants.
  • Previous treatments with G-CSF/CSF3 or GM-CSF/CSF2 showed transient effects on blood cell counts but did not improve wound healing in affected individuals.

Purpose of the Study:

  • To investigate the underlying mechanisms of poor wound healing and immune dysregulation in PN patients with USB1 mutations.
  • To identify novel cellular and molecular defects associated with PN.

Main Methods:

  • Analysis of peripheral blood monocytes from PN patients.
  • In vitro functional assays of patient-derived monocytes stimulated with M-CSF and IL-34.
  • RNA sequencing (RNAseq) of monocytes to identify differentially expressed genes.
  • Measurement of plasma cyclic adenosine monophosphate (cAMP) levels.

Main Results:

  • PN patients exhibited a lack of non-classical monocytes (CD14+/- CD16+) and a systemic inflammatory cytokine profile.
  • Patient monocytes showed impaired responses to M-CSF and IL-34, despite normal receptor expression.
  • RNAseq revealed downregulation of genes involved in leukocyte differentiation and cAMP signaling, including GATA2, AKAP6, and PDE4DIP.
  • Significantly reduced plasma cAMP levels were observed in PN patients.

Conclusions:

  • This study identifies a novel association between PN and the absence of non-classical monocytes.
  • Defects in monocyte plasticity and cAMP signaling, stemming from USB1 mutations, likely contribute to the clinical manifestations of PN.